Skip to main content

Table 1 Average ADC, rCBV and metabolite ratios in low-grade gliomas and non-neoplastic lesions

From: Contribution of advanced neuro-imaging (MR diffusion, perfusion and proton spectroscopy) in differentiation between low grade gliomas GII and MR morphologically similar non neoplastic lesions

Group n ADC (mean ± SD) rCBV (mean ± SD) Cho/Cr (mean ± SD) Cho/NAA (mean ± SD) NAA/Cr (mean ± SD)
Low-grade glioma 12 1.13 ± 0.32 1.27 ± 0.45 2.14 ± 0.71 3.34 ± 1.5 0.62 ± 0.3
All non-neoplastic lesions 27 1.2 ± 0.5 0.75 ± 0.22 1.65 ± 1.1 1.5 ± 1.6 1.46 ± 1.5
Tumefactive demyelination 7 0.96 ± 0.14 1 ± 0.2 1.85 ± 0.9 2.2 ± 2 1 ± 0.5
Tuberculoma 4 1.4 ± 0.4 0.8 ± 0.2 1.4 ± 0.33 1.14 ± 0.3 1.3 ± 0.7
Cavernoma 4 1.3 ± 0.5 0.45 ± 0.12 0.78 ± 0.5 0.66 ± 0.33 1.4 ± 1.1
Ischemia 4 0.97 ± 0.6 0.74 ± 0.14 1.1 ± 0.3 0.33 ± 0.2 4.4 ± 2
Encephalitis 3 1.65 ± 0.5 0.83 ± 0.03 1.58 ± 0.3 1.52 ± 0.3 1 ± 0.1
Vasculitis 2 1.65 ± 0.3 0.92 ± 0.2 1.34 ± 0.4 1.5 ± 0.5 0.96 ± 0.1
Pyogenic abcess 2 0.64 ± 0.04 0.49 ± 0.04 3.96 ± 0.76 4.26 ± 1.2 0.67 ± 0.2
Tylor cortical dysplasia 1 1 0.8 1.2 0.61 1.98
P valuea 0.74 < 0.001* 0.045* 0.002* 0.003*
  1. The cut of value and the important numbers are also in bold
  2. *Statistically significant
  3. aP value for comparison between low-grade gliomas and all non-neoplastic lesions